Literature DB >> 7275185

Enhancement of monocyte complement component synthesis by antigen--antibody complexes.

A McPhaden, D Lappin, K Whaley.   

Abstract

Antigen--antibody complexes were found to enhance the synthesis of the complement components C2, C4, C3, C5, factor B, properdin, C3b inactivator and beta 1H by human monocytes in tissue culture. The synthesis of all components was increased by complexes in a dose-dependent fashion. Insoluble complexes formed at equivalence (antigen--antibody ratio 2:1) were more effective than complexes formed at eight times antigen excess (antigen--antibody ratio 16:1), two times antigen excess (antigen--antibody ratio 4:1) or four times antibody excess (antigen--antibody ratio 1:2). The latter three species of complexes each consist of a mixture of soluble and insoluble complexes. It was shown that total complexes (soluble and insoluble) were more potent than soluble complexes at stimulating complement component synthesis. Soluble complexes of different molecular sizes were prepared by gel-filtration chromatography; larger complexes enhance C2 synthesis to a greater extent than small complexes. The enhanced synthesis of the functionally active complement components by mononuclear phagocytes induced by antigen--antibody complexes probably facilitates the handling of complexes by promoting their solubilization and degradation.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7275185      PMCID: PMC1555139     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  16 in total

1.  A radio-immunoelectrophoretic assay for human growth hormone.

Authors:  W M Hunter; F C Greenwood
Journal:  Biochem J       Date:  1964-04       Impact factor: 3.857

2.  Requirements for the solubilization of immune aggregates by complement. The role of the classical pathway.

Authors:  M Takahashi; S Takahashi; V Brade; V Nussenzweig
Journal:  J Clin Invest       Date:  1978-08       Impact factor: 14.808

3.  The role of complement in the binding and degradation of immunoglobulin aggregates by macrophages.

Authors:  A Kijlstra; L A van Es; M R Daha
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

4.  Enhanced degradation of soluble immunoglobulin aggregates by macrophages in the presence of complement.

Authors:  A Kijlstra; L A Van Es; M R Daha
Journal:  Immunology       Date:  1979-07       Impact factor: 7.397

5.  Activation of the alternative complement pathway due to resistance of zymosan-bound amplification convertase to endogenous regulatory mechanisms.

Authors:  D T Fearon; K F Austen
Journal:  Proc Natl Acad Sci U S A       Date:  1977-04       Impact factor: 11.205

6.  Activation of the alternative complement pathway with rabbit erythrocytes by circumvention of the regulatory action of endogenous control proteins.

Authors:  D T Fearon; K F Austen
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

7.  Requirements for the solubilization of immune aggregates by complement: assembly of a factor B-dependent C3-convertase on the immune complexes.

Authors:  M Takahashi; B F Tack; V Nussenzweig
Journal:  J Exp Med       Date:  1977-01-01       Impact factor: 14.307

8.  Studies on the mechanism of solubilization of immune precipitates by serum.

Authors:  J Czop; V Nussenzweig
Journal:  J Exp Med       Date:  1976-03-01       Impact factor: 14.307

9.  Synthesis of the second component of complement by long-term primary cultures of human monocytes.

Authors:  L P Einstein; E E Schneeberger; H R Colten
Journal:  J Exp Med       Date:  1976-01-01       Impact factor: 14.307

10.  Receptors for complement of leukocytes.

Authors:  W H Lay; V Nussenzweig
Journal:  J Exp Med       Date:  1968-11-01       Impact factor: 14.307

View more
  8 in total

Review 1.  Complement biosynthesis by mononuclear phagocytes.

Authors:  A R McPhaden; K Whaley
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

Review 2.  Synthesis of complement by macrophages and modulation of their functions through complement activation.

Authors:  H P Hartung; U Hadding
Journal:  Springer Semin Immunopathol       Date:  1983

3.  Requirement for cations in the stimulation of C2 synthesis by human monocytes.

Authors:  D Lappin; K Whaley
Journal:  Immunology       Date:  1985-03       Impact factor: 7.397

4.  Cyclic nucleotides and their relationship to complement-component-C2 synthesis by human monocytes.

Authors:  D Lappin; D W Riches; B Damerau; K Whaley
Journal:  Biochem J       Date:  1984-09-01       Impact factor: 3.857

5.  Role of C3 in the control of monocyte C2 production.

Authors:  A O Hamilton; L Morrison; W S Kilpatrick; D Lappin; J C Bensa; D W Riches; K Whaley
Journal:  Immunology       Date:  1984-01       Impact factor: 7.397

6.  Increased C3 production in human monocytes after stimulation with Candida albicans is suppressed by granulocyte-macrophage colony-stimulating factor.

Authors:  A K Høgåsen; T G Abrahamsen
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

7.  Serum-treated antigen-antibody complexes inhibit the production of C2 and factor B by mononuclear phagocytes.

Authors:  K Whaley; D Lappin; A O Hamilton
Journal:  Immunology       Date:  1983-02       Impact factor: 7.397

8.  Regulation of elastase and plasminogen activator secretion in resident and inflammatory macrophages by receptors for the Fc domain of immunoglobulin G.

Authors:  R Takemura; Z Werb
Journal:  J Exp Med       Date:  1984-01-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.